Exodus Point Capital Management, LP Arcellx, Inc. Transaction History

Exodus Point Capital Management, LP

  • $16.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
BUY
$31.51 - $37.4 $1.2 Million - $1.42 Million
37,952 New
37,952 $1.36 Million
Q3 2022

Nov 10, 2022
SELL
$16.67 - $22.04 $1.07 Million - $1.41 Million
-64,021 Closed
0 $0
Q2 2022

Aug 19, 2022
BUY
$7.21 - $24.43 $461,591 - $1.56 Million
64,021 New
64,021 $1.16 Million

Others Institutions Holding ACLX

# of Institutions
205
Shares Held
44.2M
Call Options Held
2.23M
Put Options Held
907K
View Full List

About Arcellx, Inc.

ACLX Quotes by TradingView
  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $3.85B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email